top of page


Three-prong treatment eliminates cancer tumors in five minutes
Researchers have developed a nanoplatform that non-invasively eliminates solid liver cancer tumors with a single five-minute dose.
Joseph Shavit
Feb 15, 2022


Prostate cancer antibody drug shows success in dogs
Dogs are proving to be a far better scientific model for study of prostate cancer than mice, the typical animal used in the lab.
Joseph Shavit
Feb 8, 2022


MIT researchers make RNA vaccines easier to swallow
Researchers has developed a way to deliver RNA in a capsule that can be swallowed, which they hope could make people more receptive to them.
Joseph Shavit
Feb 1, 2022


Blood iron levels could be key to slowing ageing
Genetic data suggests that maintaining healthy levels of iron in the blood could be a key to ageing better and living longer.
Joseph Shavit
Feb 1, 2022


Carbon nanotubes could be the answer to anticancer drug delivery
The key is that the nanotubes pull the liposomes and the cancer cells together, allowing the membranes of the liposome and cancer to mix.
Joseph Shavit
Jan 29, 2022


It's not a COVID cure but study finds hydroxychloroquine may treat multiple sclerosis
Hydroxychloroquine, also known by the brand name Plaquenil, is a prescription drug that is used in the treatment of malaria and arthritis.
Joseph Shavit
Jan 17, 2022


New therapy found to swiftly reduce depression and suicidal thoughts
Ketamine therapy has a swift short-term effect on reducing symptoms of depression and suicidal thoughts, according to research.
Joseph Shavit
Dec 27, 2021


Shape-changing microrobots dispense medicine directly to cancer cells
Researchers have now created tiny shape-changing microrobots that can deliver medications directly to the cells where they’re needed.
Joseph Shavit
Nov 30, 2021


Cost-effective new drug to treat lung cancer is finally here
Most recent lung cancer research focuses on anti-angiogenic therapy, a cancer treatment that uses anti-cancer drugs to block angiogenesis.
Joseph Shavit
Nov 26, 2021


New test determines antibiotic resistance in less than 90 minutes rather than 3 days
This discovery means that doctors could quickly know which antibiotics will or won’t work for a patient’s life-threatening infection.
Joseph Shavit
Nov 4, 2021


New cost-effective drug to treat lung cancer is finally here
Most recent lung cancer research focuses on anti-angiogenic therapy, a cancer treatment that uses anti-cancer drugs to block the tumor.
Joseph Shavit
Oct 16, 2021


Anti-nausea drug may help some cancer patients survive longer
Patients with breast, pancreatic and certain other types of cancer may survive longer if given an anti-nausea drug during surgery.
Joseph Shavit
Oct 11, 2021


Cancer chemotherapy drug reverses Alzheimer’s symptoms in mice
A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer’s disease.
Joseph Shavit
Oct 7, 2021


Great news in the treatment of lung cancer for those that have never smoked
Despite smoking’s well-known role in causing lung cancer, a significant number of patients who develop lung tumors have never smoked.
Joshua Shavit
Oct 6, 2021


Common Diabetes medications may prevent Glaucoma
A popular class of diabetes medications (Trulicity and Rybelsus) may also protect against glaucoma in diabetic patients.
Joseph Shavit
Sep 22, 2021


Start-up funded by the US Army develops a pill that might cure PTSD
A start-up, funded in part by the U.S. Army, could be on track to revolutionizing what we know about PTSD.
Joseph Shavit
Sep 11, 2021


New room-temperature COVID-19 vaccines are grown in plants and bacteria
Researchers have developed COVID-19 vaccine candidates that can take the heat. Their key ingredients? Viruses from plants or bacteria.
Joshua Shavit
Sep 10, 2021


First-in-human clinical trial for a vaccine to treat opioid use disorders enrolls first patients
First ever trial to study a therapeutic vaccine for opioid use disorder developed by researchers at the University of Minnesota.
Joshua Shavit
Sep 10, 2021


The first experimental opioid vaccine is being tested at Columbia University
The first experimental vaccine to be tested in the US for treatment of opioid use disorder is being studied in a phase 1a/1b clinical trial.
Joseph Shavit
Sep 8, 2021


Drug delivery capsule could replace injections for cancer and autoimmune disorders
In recent years, scientists have developed monoclonal antibodies, proteins that mimic the body’s own immune defenses.
Joshua Shavit
Sep 5, 2021
bottom of page